L04AC07 tocilizumab
ATC group of level 5 – chemical substance · in plain English: medicines suppressing the immune system, e.g. after a transplant or for autoimmune diseases
This site has the patient leaflet or the SPC of 9 medicines in this group.
- 8 prescription only (POM)
Active substance: Tocilizumab – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L04 Immunosuppressants 545 medicines
- L04A Immunosuppressants 543 medicines
- L04AC Interleukin inhibitors 78 medicines
- L04AC07 tocilizumab 9 medicines
- L04AC Interleukin inhibitors 78 medicines
- L04A Immunosuppressants 543 medicines
- L04 Immunosuppressants 545 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Avtozma 162 mg solution for injection in Pre-filled syringe SPC | Prescription only (POM) |
| Roactemra 162 mg solution for injection in Pre-filled pen SPC | Prescription only (POM) |
| Roactemra 162 mg solution for injection in Pre-filled syringe SPC | Prescription only (POM) |
| Roactemra 20 mg / ml concentrate for solution for infusion SPC | Prescription only (POM) |
| Tuyory 162 mg solution for injection in Pre-filled pen SPC | Prescription only (POM) |
| Tuyory 162 mg solution for injection in Pre-filled syringe SPC | Prescription only (POM) |
| Tuyory 20 mg/ml concentrate for solution for infusion SPC | – |
| Tyenne 162 mg solution for injection in Pre-filled pen SPC | Prescription only (POM) |
| Tyenne 162 mg solution for injection in Pre-filled syringe | Prescription only (POM) |
Other groups of the same level
- L04AC01 daclizumab 1 medicine
- L04AC02 basiliximab 4 medicines
- L04AC03 anakinra 1 medicine
- L04AC05 ustekinumab 16 medicines
- L04AC08 canakinumab 5 medicines
- L04AC10 secukinumab 6 medicines
- L04AC11 siltuximab 3 medicines
- L04AC12 brodalumab 1 medicine
- L04AC13 ixekizumab 5 medicines
- L04AC14 sarilumab 4 medicines
- L04AC16 guselkumab 7 medicines
- L04AC17 tildrakizumab 4 medicines
- L04AC18 risankizumab 9 medicines
- L04AC19 satralizumab 1 medicine
Other names of the ATC group
- Czech: L04AC07 Tocilizumab
- French: L04AC07 tocilizumab
- German: L04AC07 Tocilizumab
- Spanish: L04AC07 TOCILIZUMAB
- German: L04AC07 Tocilizumab
- Italian: L04AC07 TOCILIZUMAB
- Polish: L04AC07 TOCILIZUMAB
- Turkish: L04AC07 tocilizumab
- Portuguese (Brazil): L04AC07 Tocilizumab
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L04AC07
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.